Efficacy, immunogenicity and safety of respiratory syncytial virus prefusion F vaccine: systematic review and meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Efficacy, immunogenicity and safety of respiratory syncytial virus prefusion F vaccine: systematic review and meta-analysis ; volume:24 ; number:1 ; day:6 ; month:5 ; year:2024 ; pages:1-13 ; date:12.2024
BMC public health ; 24, Heft 1 (6.5.2024), 1-13, 12.2024
- Creator
-
Pang, Yi
Lu, Haishan
Cao, Demin
Zhu, Xiaoying
Long, Qinqin
Tian, Fengqin
Long, Xidai
Li, Yulei
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12889-024-18748-8
- URN
-
urn:nbn:de:101:1-2407152102117.370244249969
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pang, Yi
- Lu, Haishan
- Cao, Demin
- Zhu, Xiaoying
- Long, Qinqin
- Tian, Fengqin
- Long, Xidai
- Li, Yulei
- SpringerLink (Online service)
Other Objects (12)
Protective efficacy and immunogenicity of a combinatory DNA vaccine against influenza A virus and the respiratory syncytial virus
Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
Immunogenicity of an AS01-adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in animal models
Patient equity and respiratory syncytial virus Immunoprophylaxis
Immunogenicity of infectious pathogens and vaccine antigens
Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice
Respiratory Syncytial Virus Maternal Vaccination in Infants below 6 Months of Age: Meta-Analysis of Safety, Immunogenicity, and Efficacy
Challenges and opportunities for respiratory syncytial virus vaccines
Severe Respiratory Syncytial Virus Infection
Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model
A computational approach to design a polyvalent vaccine against human respiratory syncytial virus
Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine During Pregnancy for Prevention of Respiratory Syncytial Virus Among Infants in Argentina
Protective efficacy and immunogenicity of a combinatory DNA vaccine against influenza A virus and the respiratory syncytial virus
Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
Immunogenicity of an AS01-adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in animal models
Patient equity and respiratory syncytial virus Immunoprophylaxis
Immunogenicity of infectious pathogens and vaccine antigens
Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice
Respiratory Syncytial Virus Maternal Vaccination in Infants below 6 Months of Age: Meta-Analysis of Safety, Immunogenicity, and Efficacy
Challenges and opportunities for respiratory syncytial virus vaccines
Severe Respiratory Syncytial Virus Infection
Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model
A computational approach to design a polyvalent vaccine against human respiratory syncytial virus
Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine During Pregnancy for Prevention of Respiratory Syncytial Virus Among Infants in Argentina
Protective efficacy and immunogenicity of a combinatory DNA vaccine against influenza A virus and the respiratory syncytial virus
Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
Immunogenicity of an AS01-adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in animal models
Patient equity and respiratory syncytial virus Immunoprophylaxis
Immunogenicity of infectious pathogens and vaccine antigens
Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice
Respiratory Syncytial Virus Maternal Vaccination in Infants below 6 Months of Age: Meta-Analysis of Safety, Immunogenicity, and Efficacy
Challenges and opportunities for respiratory syncytial virus vaccines
Severe Respiratory Syncytial Virus Infection
Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model
A computational approach to design a polyvalent vaccine against human respiratory syncytial virus